Statistics for IDEXX Laboratories (id:7105 IDXX)

Valuation metrics

Market cap

34.47B

Enterprise value

35.16B

Trailing P/E (ttm)

40.67

Forward P/E

35.19

PEG ratio

35.19

Price/Sales (ttm)

8.96

Price/Book (mrq)

21.34

Enterprise Value/Revenue

9.14

Enterprise Value/EBITDA

27.06

Overview

Shares outstanding

81.88M

Float

80.97M

Shares short

2.08M

% Held by insiders

0.01%

% Held by institutions

0.94%

Average volume (10 days)

735.38K

Average volume (90 days)

Price summary

52-Week low

404.74

52-Week high

583.39

52-Week change

-14.23%

Beta

1.36

50-Day moving average

468.32

200-Day moving average

498.48

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

June 16th, 2015

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

22.53%

Operating margin

37.46%

Operational effectiveness

Return on assets

22.79%

Return on equity

59.42%

Income statement

Revenue (ttm)

46.45

Revenue per share (ttm)

46.45

Quarterly revenue growth (yoy)

0.10

Gross profit (ttm)

2.19B

EBITDA

1.25B

Net income to common (ttm)

866.24M

Diluted EPS (ttm)

10.35

Quarterly earnings growth (yoy)

9.70%

Balance sheet

Total cash (mrq)

308.64M

Total cash per share (mrq)

3.77

Total debt (mrq)

998.28M

Total Debt/Equity (mrq)

61.70

Current ratio (mrq)

142.10%

Book value per share (mrq)

19.72

Cash flow

Cash flow statement

916.83M

Levered free cash flow (LFCF)

792.04M